VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering ...

Dr. Coller, a Bloomberg Distinguished Professor of RNA Biology and Therapeutics, brings deep expertise to accelerate synthetic DNA and mRNA ...

An eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene ...

Qualcomm Tenstorrent acquisition talks value the RISC-V AI chip startup at up to $10 billion — nearly triple its prior ...

Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...

Stranger Things Tales From ‘85 Season 2 is confirmed for fall 2026 on Netflix, targeting a pre-Halloween premiere. Season 1 ...

Plc - 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board PR Newswire LONDON, United Kingdom, June 15 4basebio ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First Reverse-Aging Drug, ER-100, Is Injected Into a Human appeared first on The Hearty ...

The treatment, administered at Schneider Children’s Medical Center of Israel in Petah Tikva, is a major milestone in the development of precision genetic therapies for rare neurological disorders.

Taysha Gene Therapies on Wednesday proposed a $200 million underwritten public offering of its stock and prefunded warrants, which will support development of its gene therapy for Rett syndrome.

Spread the love“`html In today’s visually driven world, the ability to remove background from image files is an essential skill, whether you’re a graphic designer, a marketer, or just someone wanting ...